| |
| |
| |
|
| |
| |
Target Audience
This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, nurse practitioners involved in the management of chronic liver disease.
|
|
| |
| |
Upon completion of this activity, participants should be better able to:
- Understand how to diagnose overt hepatic encephalopathy (OHE)
- Know the common neurologic manifestations of OHE
- Review the general principles of management of HE
|
|
| |
Purdue University School of Pharmacy designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release - February 26, 2010
Expiration - February 26, 2011
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Education (ACCME) through the joint sponsorship of Purdue University School of Pharmacy and Focus Medical Communications. Purdue University School of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University School of Pharmacy
are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material.
Dr. Flamm is a consultant/speaker bureau and has an advisory board membership with Salix Pharmaceuticals. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
The Focus Medical Communications staff and Purdue University School of Pharmacy staff have no relationships to disclose.
|
|
|
|
|
